Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
acquired immunodeficiency syndrome dementia complex
acquired immunodeficiency syndrome, older adults
activated protein C resistance
aducanumab
advance directives
advances in neurology
adverse drug reaction
aerobic exercise
age associated memory impairment
aggression
agitation
algorithm
aluminum
Alzheimer's disease
Alzheimer's disease, conjugal
Alzheimer's disease, diagnosis of
Alzheimer's disease, driving with
Alzheimer's disease, early onset
Alzheimer's disease, early symptoms
Alzheimer's disease, familial
Alzheimer's disease, familial, late onset
Alzheimer's disease, incidence
Alzheimer's disease, misdiagnosis
Alzheimer's disease, pathogenesis
Alzheimer's disease, patient awareness of
Alzheimer's disease, preclinical
Alzheimer's disease, rapidly progressive
Alzheimer's disease, rate of clinical decline
Alzheimer's disease, risk factors in
Alzheimer's disease, treating associated medical problems in
Alzheimer's disease, treatment of
amnesia
amyloid
amyloid beta protein
amyloid beta protein antibodies
amyloid deposition
amyloid imaging
amyloid plaques
amyloidosis
amyloid-related imaging abnormalities
amyotrophic lateral sclerosis
anatomy of
angiotensin II receptor blocker
anti-amyloid therapy
anticoagulant, treatment
anticonvulsants
antihypertensive
antiphospholipid antibodies
antithrombin III deficiency
anxiety
apolipoprotein E
apoliprotein E, plasma level
APP
APP gene
asymptomatic
atrial fibrillation
atypical
automobile accidents
autonomic dysfunction
behavioral disorder
benzodiazepine
biologic markers
blacks
blood pressure
blood transfusion
bone density
carcinoma
caregiver
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, venography
cerebral edema
cerebral edema, vasogenic
cerebral infarction
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebral venous thrombosis, etiology
cerebral venous thrombosis, recurrent
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, familial occurrence
cerebrovascular accident, infancy and childhood
cerebrovascular accident, prevention of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
cerebrovascular disease
cerebrovascular disease, risk factors in
children
chromosomal abnormality
chromosome 12
cigarette smoking
clinical trials
cognition
comorbidities
complications
confusion
contraindications
controversies in neurology
cost
coumarin
craniectomy, decompressive
D-dimer
degenerative diseases of CNS
dementia
dementia, cerebrovascular disease causing
dementia, clinical diagnosis
dementia, diagnostic evaluation of
dementia, differential diagnosis of
dementia, driving with
dementia, early detection
dementia, familial
dementia, incidence
dementia, prevalence of
dementia, prevention of
dementia, rapidly progressive
dementia, screening for
dementia, treatment of
depression
diabetes mellitus
diagnostic criteria
disease modifying agents
dizziness
donanemab
donepezil
driving
drug abuse
dural sinus thrombosis
educational status
efficacy
electromagnetic fields
endovascular therapy
epidemiology of neurology
ethics in neurology
evidence-based research
exercise
Factor V Leiden
familial
fibrinolytic agents
fibrinolytic agents, intra-venous local infusion
fibrinolytic agents, utilization
fracture, long bone
gadolinium
gantenerumab
gender
gene
genetic counselling
genetic linkage
genetic neurologic disorders
genetic screening
genetic testing
glaucoma
haloperidol
head injury
headache
hemiparesis
hemosiderosis of CNS, superficial
heralding manifestation
herpes simplex virus
hip fracture
hippocampal atrophy
hippocampus
Hispanics
homocysteine, serum
homosexual
hormone replacement
hormone therapy
human immunodeficiency virus type 1
hydrocephalus
hypercholesterolemia
hyperhomocysteinemia
hyperinsulinism
hypertension
hypoxia
iatrogenic neurologic disorders
incidence
intellectual deficit
intellectual deterioration
intracerebral hemorrhage
intracranial pressure, increased
inverse association
Jakob-Creutzfeldt disease
lecanemab
leisure activity
level of consciousness, decreased
lifestyle
limbic system
limbic-predominant age-related TDP-43 encephalopathy
lipid lowering agent
managed care
marital status
medical-legal aspects of neurology
memory
memory, defect of recent
memory, evaluation of
memory, impairment of
memory, impairment of, isolated
memory, impairment of, subjective
meningitis
menopause
mental activity
mental status, abnormal
mesial temporal lobe
microhemorrhage, intracerebral
middle cerebral artery territory infarction
middle cerebral artery, occlusion of
mild cognitive impairment
mild cognitive impairment converting to Alzheimer's disease
mimics
Mini Mental Status Examination
misdiagnosis
molecular genetics
mongolism
monoclonal antibodies
mortality
motor neuron disease
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, functional
MRI, venography
multiple sclerosis
myoclonus
negative
nerve growth factor
neurofibrillary degeneration
neuroleptic
neuroleptic, atypical
neurologic complications of, systemic disease
neurologic consultation
neurologic disease, diagnoses of
neurologic evaluation
neurologic examination, focal
neurologic signs
neurologic symptoms
neuropathology
neuropathy
neuroprotective agents
nicotine
nonsteroidal anti-inflammatory drug
normal
occupational neurologic disorders
old age, driving and
old age, neurology of
oral contraceptives
oral contraceptives, cerbrovascular disease and
oral contraceptives, neurologic complications with
osteoporosis
Parkinson disease
Parkinson disease, etiology of
patient information and support
pitfalls
Pittsburgh Compound B
placebo
polysomnogram
practice guidelines
preclinical
pregnancy, neurologic complications in
premarin
presenilin-1 gene
presenilin-2 gene
prethrombotic state
prevention of neurologic disorders
progesterone
prognosis
protein C deficiency
protein S deficiency
proteinopathy
psychological testing
psychotic behavior
remternetug
research
review article
rhinorrhea, CSF
risk factors
risk factors, modification
risk-benefit assessment
risperidone
rosacea
safety
screening
seizure
seizure, elderly
seizure, focal
seizure, risk factors for
selective serotonin reuptake inhibitors
senile plaques
shared decision making
sildenafil
skin, lesions in neurologic disorders
sleep
sleep pathology and physiology
smell
Smell Identification Test
sodium-glucoe cotransporter-2 inhibitors
straight sinus
stress, emotional
superior sagittal sinus thrombosis
tau protein
TDP-43 proteinopathy
temporal lobe, atrophy
tissue plasminogen activator, intravenous
TRAILBLAZER-ALZ trial
treatment of neurologic disorder
TREM2 variants
water, drinking
weight loss
white matter disease
whites
workup
Showing articles 300 to 350 of 7284 << Previous Next >>

Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019

Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared with Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke
JAMA Neurol 76:774-782, Tillman, H.,et al, 2019

Cerebral Microbleeds
Neurol 92:e253-e262, Graff-Radford, J.,et al, 2019

Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis
JAMA 32:175-187, Brown, J.W.L.,et al, 2019

Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis
JAMA 32:165-174,153, Burt, R.K.,et al, 2019

Cholesterol Lowering and Prevention of Stroke
Stroke 50:537-541, Hackam, D.G. & Hegele, R.A., 2019

Stroke Incidence and Impact of Continuous-Flow Left Ventricular Assist Devices on Cerebrovascular Physiology
Stroke 50:542-548, Cornwell, W.K.,et al, 2019

Perioperative Cerebral Microbleeds After Adult Cardiac Surgery
Stroke 50:336-343, Patel, N.,et al, 2019

Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage
Stroke 50:529-536, Bower, M.M.,et al, 2019

Simultaneous CMV and Listeria Infection Following Alemtuzumab Treatment for Multiple Sclerosis
Neurol 92:296-298, Pappolla, A.,et al, 2019

A 15-year-old Boy with Bilateral Wrist Pain in the Setting of Weight Loss
Neurol 92:486-492, Lau, K.H.V.,et al, 2019

Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Womens Health Initiative
Stroke 50:555-562,549, Mossavar-Rahmani, Y.,et al, 2019

Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies
Neurol 92:663-674, Johansen, A.,et al, 2019

Acute Encephalitis in Immunocompetent Adults
Lancet 393:702-716, Venkatesan, A.,et al, 2019

Incidence of Stroke After Pneumonectomy and Lobectomy
Stroke 50:1052-1059, Riddersholm, S.,et al, 2019

Central Nervous System Infections Due to Coccidioidomycosis
J Fungi 5:2-12, Jackson, N.R.,et al, 2019

Diagnostic Tools for Immune Causes of Encephalitis
Clin Microbiol Infect 25:431-436, Lascano, A.M.,et al, 2019

The So-Called "Bovine Aortic Arch": A Possible Biomarker for Embolic Strokes?
Neuroradiology 61:1165-1172, Syperek, A.,et al, 2019

RCVS2 Score and Diagnostic Approach for Reversible Cerebral Vasoconstriction Syndrome
Neurol 92:e639-e647, Rocha, E.A.,et al, 2019

Pharmacologic Treatment for Pediatric Migraine Prevention
Neurol 93:500-509, Oskoui, M.,et al, 2019

Smoking and Stroke: A Mendelian Randomization Study
Ann Neurol 86:468-471, Larsson, S.C.,et al, 2019

Fremanezumab versus Placebo for Migraine Prevention in Patients with Documented Failure to Up to Four Migraine Preventive Medication Classes (FOCUS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3� Trial
Lancet 394:1030-1040, Ferrari, M.D.,et al, 2019

Long-Term Safety and Efficacy of Eculizumab in Generalized Myasthenia Gravis
Muscle Nerve 60:14-24, Muppidi, S.,et al, 2019

Diagnostic Impact of Intracranial Vessel Wall MRI in 205 Patients with Ischemic Stroke
AJNR 40:1701-1706,1707, Schaafsma, J.D.,et al, 2019

Reversible Cerebral Vasoconstriciton Syndrome
www.UptoDate.com, June, Singhal, A., 2019

Inebilizumab for the Treatment of Neuromyelitis Optica Spectrum Disorder (N-MOmentum): A Double-Blind, Randomised Placebo-Controlled Phase 2/3 Trial
Lancet 394:1352-1363,1304, Cree, B.A.C.,et al, 2019

Clinical Effectiveness of Direct Oral Anticoagulations vs Warfarin in Older Patients with Atrial Fibrillation and Ischemic Stroke
JAMA Neurol 76:1192-1202, Xian, Y.,et al, 2019

Tics and Functional Tic-Like Movements
Neurol 93:750-758, Ganos, C.,et al, 2019

Postraumatic Stress Disorder and Risk for Stroke in Young and Middle-Aged Adults
Stroke 50:2996-2003, Rosman, L.,et al, 2019

Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019

Muscular Dystrophies
Lancet 394:2025-2038, Mercuri, E.,et al, 2019

Metabolic Lipid Muscle Disorders: Biomarkers and Treatment
Ther Adv Neurol Disord 12:1-15, Angelini, C.,et al, 2019

Clinical Manifestations and Diagnosis of Nocardiosis
UptoDate May, Spelman, D., 2019

Switching the Manufacturer of Antiepileptic Drugs is Associated with Higher Risk of Seizures: A Nationwide Study of Prescription Data in Germany
Ann Neurol 84:918-925, Lang, J.D.,et al, 2018

Neuroimaging Findings of Zika Virus-Associated Neurologic Complications in Adults
AJNR 39:1967-1974, Hygino da Cruz, L.C.,et al, 2018

Efficacy and Tolerability of Erenumab in Patients with Episodic Migraine in Whom Two-of-Four Previous Preventive Treatments were Unsuccessful: A Randomised, Double-Blind, Placebo-Controlled, Phase 3b Study
Lancet 392:2280-2287,2241, Reuter, U.,et al, 2018

Cranial Dural Arteriovenous Fistula
Stroke 49:332-334, Chen, P.M.,et al, 2018

Galcanezumab in Chronic Migraine
Neurol 91:e2211-e2221, Detke, H.C.,et al, 2018

Inflammatory Demyelinating Polyneuropathy Versus Leptomeningeal Disease Following Ipilimumab
J Immunother Cancer 6:11, Cafuir, L.,et al, 2018

Behcet Disease
emedicine.medscape.com Dec, Davey-Ranasinghe, N. & Diamond, H.S., 2018

Progressive multifocal leukoencephalpathy after fingolimod treatment
Neurol 90:1815-e1821, Berger, J.R.,et al, 2018

A 77-year-old man presenting with episodic expressive aphasia
Neurol 90:e1822-e1826, Shanklin, A.,et al, 2018

Diagnosis and Management of Active Intracranial Atherosclerotic Disease
Stroke 49:e221-e223, Narwal, P.,et al, 2018

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
NEJM 378:2191-2201, Hart, R.G.,et al, 2018

Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies
BMJ 360:k1717, Adderley, N.J.,et al, 2018

Postoperative Visual Loss After Anesthesia for Nonocular Surgery
UptoDate May, Lee, L.A. & Newman, N.J., 2018

Risk of Ischemic and Hemorrhagic Strokes in Occult and Manifest Cancers
Stroke 49:1585-1592, Andersen, K.K. & Olsen, T.S., 2018

Factor Xa Inhibitors Versus Vitamin K Antagonists for Prevention of Cerebral or Systemic Embolism in Patients with Atrial Fibrillation
Stroke 49:e235-e236, Bruins Slot, K.M.H. & Berge, E., 2018

Autoimmune Pancerebellitis Associated with Pembrolizumab Therapy
Neurol 91:91-93, Vitt, J.R.,et al, 2018

Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy
Neurol 91:e359-e363, Rauer,S.,et al, 2018



Showing articles 300 to 350 of 7284 << Previous Next >>